Skip to main content

Advertisement

Table 3 Disease events prevented with the nine-valent vaccine universal vaccination in comparison with the current strategy (the quadrivalent vaccine girls-only vaccination)

From: Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy

Disease event Years since start of vaccination programme
5 25 50 100
Females
 Cervical cancer 0 367 4623 22,640
 CIN 1 23 6961 34,753 105,431
 CIN 2/3 25 10,193 54,709 170,286
 Vaginal cancer 0 0 13 88
 VAIN 2/3 0 0 0 0
 Vulvar cancer 0 1 21 130
 Genital warts and HPV 6/11-related CIN 1 33 2438 6270 13,658
 Genital warts 1411 61,285 161,443 358,140
 Anal cancer 0 11 318 2619
Males
 Genital warts 6101 208,935 615,645 1508,705
 Anal cancer 0 28 748 5492